228 related articles for article (PubMed ID: 11779098)
1. Effect of recombinant human erythropoietin administration on lipid peroxidation and antioxidant enzyme(s) activities in preterm infants.
Akisu M; Tuzun S; Arslanoglu S; Yalaz M; Kultursay N
Acta Med Okayama; 2001 Dec; 55(6):357-62. PubMed ID: 11779098
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
[TBL] [Abstract][Full Text] [Related]
3. Red cell lipid peroxidation and antioxidant system in haemodialysed patients: influence of recombinant human erythropoietin (r-HuEPO) treatment.
Boran M; Küçükaksu C; Balk M; Cetin S
Int Urol Nephrol; 1998; 30(4):507-12. PubMed ID: 9821056
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant human erythropoietin on transfusion needs in preterm infants.
Yeo CL; Choo S; Ho LY
J Paediatr Child Health; 2001 Aug; 37(4):352-8. PubMed ID: 11532054
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study.
Shannon KM; Mentzer WC; Abels RI; Wertz M; Thayer-Moriyama J; Li WY; Thompson D; Decelle S; Phibbs RH
J Pediatr; 1992 Apr; 120(4 Pt 1):586-92. PubMed ID: 1372652
[TBL] [Abstract][Full Text] [Related]
6. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
Pollak A; Hayde M; Hayn M; Herkner K; Lombard KA; Lubec G; Weninger M; Widness JA
Pediatrics; 2001 Jan; 107(1):78-85. PubMed ID: 11134438
[TBL] [Abstract][Full Text] [Related]
7. Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants.
Carnielli VP; Da Riol R; Montini G
Arch Dis Child Fetal Neonatal Ed; 1998 Jul; 79(1):F44-8. PubMed ID: 9797624
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant human erythropoietin in infants with very low birth weights.
Samanci N; Ovali F; Dagoglu
J Int Med Res; 1996; 24(2):190-8. PubMed ID: 8737229
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study.
Shannon KM; Mentzer WC; Abels RI; Freeman P; Newton N; Thompson D; Sniderman S; Ballard R; Phibbs RH
J Pediatr; 1991 Jun; 118(6):949-55. PubMed ID: 2040933
[TBL] [Abstract][Full Text] [Related]
10. High Prevalence of Iron Deficiency Despite Standardized High-Dose Iron Supplementation During Recombinant Erythropoietin Therapy in Extremely Low Gestational Age Newborns.
Siddappa AM; Olson RM; Spector M; Northrop E; Zamora T; Brearley AM; Georgieff MK; Rao R
J Pediatr; 2020 Jul; 222():98-105.e3. PubMed ID: 32418819
[TBL] [Abstract][Full Text] [Related]
11. Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major.
Naithani R; Chandra J; Bhattacharjee J; Verma P; Narayan S
Pediatr Blood Cancer; 2006 Jun; 46(7):780-5. PubMed ID: 16317757
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human erythropoietin in the treatment of anemia of prematurity.
Chen JY; Wu TS; Chanlai SP
Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions.
Al-Kharfy T; Smyth JA; Wadsworth L; Krystal G; Fitzgerald C; Davis J; Milner R
J Pediatr; 1996 Jul; 129(1):89-96. PubMed ID: 8757567
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin in anemia of prematurity.
Whitehall JS; Patole SK; Campbell P
Indian Pediatr; 1999 Jan; 36(1):17-27. PubMed ID: 10709119
[TBL] [Abstract][Full Text] [Related]
15. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer.
Kaynar H; Meral M; Turhan H; Keles M; Celik G; Akcay F
Cancer Lett; 2005 Sep; 227(2):133-9. PubMed ID: 16112416
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 2 iron doses in infants receiving recombinant human erythropoietin therapy.
Nazir S; Peverini RL; Deming DD; Hopper AO; Vyhmeister NR
Arch Pediatr Adolesc Med; 2002 Jun; 156(6):540-4. PubMed ID: 12038884
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response.
Rutherford CJ; Schneider TJ; Dempsey H; Kirn DH; Brugnara C; Goldberg MA
Am J Med; 1994 Feb; 96(2):139-45. PubMed ID: 8109598
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity.
Bechensteen AG; Hågå P; Halvorsen S; Whitelaw A; Liestøl K; Lindemann R; Grøgaard J; Hellebostad M; Saugstad OD; Grønn M
Arch Dis Child; 1993 Jul; 69(1 Spec No):19-23. PubMed ID: 8346946
[TBL] [Abstract][Full Text] [Related]
19. Serum malondialdehyde, erythrocyte glutathione peroxidase, and erythrocyte superoxide dismutase levels in women with early spontaneous abortions accompanied by vaginal bleeding.
Ozkaya O; Sezik M; Kaya H
Med Sci Monit; 2008 Jan; 14(1):CR47-51. PubMed ID: 18160945
[TBL] [Abstract][Full Text] [Related]
20. Effect of low and moderate doses of recombinant human erythropoietin on the haematological response in premature infants on a high protein and iron intake.
Bechensteen AG; Hågå P; Halvorsen S; Liestøl K; Lindemann R; Whitelaw A; Tølløfsrud PA; Daae L; Thorstensen K; Sundal E
Eur J Pediatr; 1997 Jan; 156(1):56-61. PubMed ID: 9007493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]